Spanish Breast Cancer Research Group
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.geicam.org
Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 63
- Registration Number
- NCT00129376
- Locations
- 🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸Fundación Jiménez Díaz, Madrid, Spain
🇪🇸Hospital de la Ribera, Alcira, Valencia, Spain
Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2005-08-10
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 46
- Registration Number
- NCT00128856
- Locations
- 🇪🇸
Hospital Universitario La Princesa, Madrid, Spain
🇪🇸Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
- First Posted Date
- 2005-08-10
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 288
- Registration Number
- NCT00128778
- Locations
- 🇪🇸
Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes, Madrid, Spain
Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients
- First Posted Date
- 2005-08-10
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 103
- Registration Number
- NCT00128843
- Locations
- 🇪🇸
Ruber Internacional, Madrid, Spain
🇪🇸H Universitario Miguel Servet, Zaragoza, Spain
🇪🇸Hospital Donostia, Donostia-San Sebastián, Guipúzcoa, Spain
Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 252
- Registration Number
- NCT00128310
- Locations
- 🇪🇸
Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes, Madrid, Spain
🇻🇪Grupo Andino de Investigación en Oncología (GAICO), Valencia, Venezuela
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 152
- Registration Number
- NCT00128297
- Locations
- 🇪🇸
Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes, Madrid, Spain
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
- Conditions
- Interventions
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 1060
- Registration Number
- NCT00121992
- Locations
- 🇪🇸
Spanish Breast Cancer Research Group, San Sebastián de los Reyes, Madrid, Spain